AP125A - Pharmaceutical compositions for the regeneration of leukocytes and their use in the treatment of aquired immuno-deficiency syndrome - Google Patents

Pharmaceutical compositions for the regeneration of leukocytes and their use in the treatment of aquired immuno-deficiency syndrome Download PDF

Info

Publication number
AP125A
AP125A APAP/P/1990/000157A AP8900157A AP125A AP 125 A AP125 A AP 125A AP 8900157 A AP8900157 A AP 8900157A AP 125 A AP125 A AP 125A
Authority
AP
ARIPO
Prior art keywords
tetrahydroacridine
pharmaceutical compositions
group
amino
lymphocytes
Prior art date
Application number
APAP/P/1990/000157A
Other languages
English (en)
Other versions
AP8900157A0 (en
Inventor
Francois Deitlin
Daniéle Fredj
Original Assignee
S C R Newpharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by S C R Newpharm filed Critical S C R Newpharm
Publication of AP8900157A0 publication Critical patent/AP8900157A0/xx
Application granted granted Critical
Publication of AP125A publication Critical patent/AP125A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/08—Nitrogen atoms
    • C07D219/10—Nitrogen atoms attached in position 9

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
APAP/P/1990/000157A 1988-12-19 1989-12-18 Pharmaceutical compositions for the regeneration of leukocytes and their use in the treatment of aquired immuno-deficiency syndrome AP125A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR888816749A FR2640508B1 (fr) 1988-12-19 1988-12-19 Nouvelles compositions et nouveaux produits pharmaceutiques assurant la regeneration de leucocytes et leur emploi pour le traitement du syndrome immuno-deficitaire

Publications (2)

Publication Number Publication Date
AP8900157A0 AP8900157A0 (en) 1990-01-31
AP125A true AP125A (en) 1991-03-19

Family

ID=9373109

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1990/000157A AP125A (en) 1988-12-19 1989-12-18 Pharmaceutical compositions for the regeneration of leukocytes and their use in the treatment of aquired immuno-deficiency syndrome

Country Status (19)

Country Link
EP (1) EP0375471B1 (ko)
JP (1) JPH02258722A (ko)
KR (1) KR900009075A (ko)
AP (1) AP125A (ko)
AT (1) ATE136463T1 (ko)
AU (2) AU4686189A (ko)
CA (1) CA2005925C (ko)
DE (1) DE68926222D1 (ko)
DK (1) DK646489A (ko)
FR (1) FR2640508B1 (ko)
HU (1) HU213510B (ko)
IL (1) IL92759A (ko)
MA (1) MA21964A1 (ko)
MY (1) MY106032A (ko)
NZ (1) NZ231854A (ko)
OA (1) OA09250A (ko)
PT (1) PT92620B (ko)
TN (1) TNSN89135A1 (ko)
ZA (1) ZA899733B (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5155226A (en) * 1991-02-19 1992-10-13 Hoechst-Roussel Pharmaceuticals Incorporated Method for the preparation of 9-amino-1,2,3,4-tetrahydroacridine
EP0509401A1 (en) * 1991-04-19 1992-10-21 Hoechst-Roussel Pharmaceuticals Incorporated Use of 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds for the treatment of aids
RU2036198C1 (ru) * 1993-04-01 1995-05-27 Товарищество с ограниченной ответственностью "Полисан" N-МЕТИЛ-N-( α,D -ГЛЮКОПИРАНОЗИЛ) АММОНИЯ-2-(АКРИДОН-9-ОН-10-ИЛ)АЦЕТАТ(ЦИКЛОФЕРОН), ОБЛАДАЮЩИЙ ИНТЕРФЕРОНОГЕННОЙ, ПРОТИВОВИРУСНОЙ, В ТОМ ЧИСЛЕ АНТИВИЧ, АНТИПАРАЗИТАРНОЙ, АНТИПРОМОТОРНОЙ И РАДИОПРОТЕКТИВНОЙ АКТИВНОСТЬЮ

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0319429A2 (en) * 1987-12-03 1989-06-07 Mitsubishi Kasei Corporation 9-Acylamino-tetrahydroacridine derivatives and memory enhancing agent containing said derivative as active ingredient

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4916122A (en) * 1987-01-28 1990-04-10 University Of Georgia Research Foundation, Inc. 3'-Azido-2',3'-dideoxyuridine anti-retroviral composition
EP0332626A1 (en) * 1986-11-21 1989-09-20 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Compositions for treating viral infections in humans
IL86009A (en) * 1987-04-10 1991-09-16 Us Health Liposome-encapsulated phosphorylated nucleosides for treatment of retroviral diseases
US5013741A (en) * 1987-09-08 1991-05-07 Hoechst-Roussel Pharmaceuticals Incorporated N-[substituted alkylidene]-1,2,3,4-tetrahydro-9-acridinamines useful for enhancing the cholinergic function in a mammal
CH678275A5 (ko) * 1989-05-25 1991-08-30 Debiopharm Sa
US4999358A (en) * 1989-06-26 1991-03-12 Hoechst-Roussel Pharmaceuticals Inc. (1,2,3,4-tetrahydro-9-acridinimino)cyclohexane carboxylic acid and related compounds
US4999430A (en) * 1989-07-31 1991-03-12 Warner-Lambert Company Derivatives of 1,2,3,4-tetrahydro-9-acrisinamine

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0319429A2 (en) * 1987-12-03 1989-06-07 Mitsubishi Kasei Corporation 9-Acylamino-tetrahydroacridine derivatives and memory enhancing agent containing said derivative as active ingredient

Also Published As

Publication number Publication date
AU3980693A (en) 1993-08-19
ZA899733B (en) 1991-04-24
JPH02258722A (ja) 1990-10-19
AU666725B2 (en) 1996-02-22
IL92759A (en) 1994-06-24
FR2640508A1 (fr) 1990-06-22
MA21964A1 (fr) 1991-07-01
DE68926222D1 (de) 1996-05-15
DK646489A (da) 1990-06-20
HU896683D0 (en) 1990-02-28
AP8900157A0 (en) 1990-01-31
IL92759A0 (en) 1990-09-17
DK646489D0 (da) 1989-12-19
CA2005925A1 (fr) 1990-06-19
FR2640508B1 (fr) 1994-07-01
PT92620B (pt) 1995-09-12
KR900009075A (ko) 1990-07-02
MY106032A (en) 1995-02-28
ATE136463T1 (de) 1996-04-15
EP0375471B1 (fr) 1996-04-10
EP0375471A3 (fr) 1992-07-08
EP0375471A2 (fr) 1990-06-27
AU4686189A (en) 1990-06-21
CA2005925C (fr) 2002-03-26
TNSN89135A1 (fr) 1991-02-04
HU213510B (en) 1997-07-28
PT92620A (pt) 1990-06-29
NZ231854A (en) 1993-01-27
OA09250A (fr) 1992-06-30

Similar Documents

Publication Publication Date Title
CA1238277A (en) Antiviral nucleosides
JP2540576B2 (ja) 抗レトロウイルスおよびｂ型肝炎剤
RU2214238C2 (ru) Фармацевтическая композиция, обладающая противоопухолевым действием со сниженными побочными эффектами, содержащая противоопухолевый агент и производное гидроксамовой кислоты
WO1995017876A2 (en) 2,4-disulphophenyl butylnitrone, its salts, and their use as pharmaceutical spintraps
US5026716A (en) Method of treatment of anxiety and anxio-depressive disorders
AP125A (en) Pharmaceutical compositions for the regeneration of leukocytes and their use in the treatment of aquired immuno-deficiency syndrome
US6734192B1 (en) Treatment of viral infections
JPH02243666A (ja) ニューモシスティス・カリニ肺炎などの疾病の治療法および予防法そしてこれらの方法に用いる化合物および処方物
EP1210116B1 (en) Pharmaceutical combination for the treatment of viral infections containing a calcium channel blocker and a quinoline
US3979511A (en) Inhibitors of reverse transcriptase enzymes
US5541212A (en) Use of cimetidine for the control of retrovirus infections
JPS61257925A (ja) 抗ウイルスヌクレオシド
US5886000A (en) Anti-HIV agent
EP0697215A1 (en) Digestive symptom ameliorant
US5278167A (en) 6-pyridyl substituted pyrimidine derivatives
CA1340519C (en) Antiviral nucleosides
WO1989002741A1 (en) Inhibitors of hiv-reverse transcriptase to treat aids
IL85096A (en) Use of (3-azido- (3-deoxythymidine) in the treatment or prevention of infections caused by human viruses
WO2013028890A1 (en) Compositions and methods for treating viral diseases
WO1998042349A1 (en) Mixtures of at least two reverse transcriptase inhibitors and hydroxycarbamide, in particular for inhibiting retroviral spread